论文部分内容阅读
目的研究经压缩式吸入器吸入布地奈德雾化悬液治疗幼儿哮喘的临床疗效。方法选取自我院2013年5月~2014年5月收治的60例年龄小于5岁的哮喘患者作为研究对象,对患者给予压缩式吸入器雾化吸入布地奈德悬液治疗。比较治疗后1~4周患者的治疗状况。结果患者接受治疗1~4周后,总有效率分别为:96.7%、98.4%、100%,相比较明显高于第1周治疗后的总控制率(85%)。治疗1~4周后效果进行比较,差异具有统计学意义(P<0.05)。结论 5岁以下的支气管哮喘患儿在接受压缩式吸入器雾化吸入布地奈德治疗后,疗效显著,惠儿哮喘控制率得到了明显的提高,操作简单且安全性较强,在儿科临床上可进行推广使用。
Objective To study the clinical efficacy of inhalation of budesonide nebulized suspension by compressed inhaler in children with asthma. Methods Sixty 60 asthmatic patients younger than 5 years of age treated in our hospital from May 2013 to May 2014 were enrolled in this study. Patients were given inhalation of budesonide suspension by inhalation. Patients were treated 1 to 4 weeks after treatment. Results After 1 to 4 weeks of treatment, the total effective rates were 96.7%, 98.4% and 100% respectively, significantly higher than the total control rate (85%) after the first week of treatment. After 1 to 4 weeks of treatment, the differences were statistically significant (P <0.05). Conclusions Children with bronchial asthma under 5 years old have significant curative effect after inhalation of budesonide inhalation by compressed inhaler. The control rate of children with asthma has been significantly improved, which is simple and safe to operate. In pediatric clinical practice Can be promoted.